Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer

Background: To classify triple-negative breast cancer (TNBC) immunotyping using the public database, analyze the differences between subtypes in terms of clinical characteristics and explore the role and clinical significance of immune subtypes in TNBC immunotherapy.Methods: We downloaded TNBC data...

Full description

Bibliographic Details
Main Authors: Shaojun Hu, Xiusheng Qu, Yu Jiao, Jiahui Hu, Bo Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.710534/full
_version_ 1819045859701030912
author Shaojun Hu
Xiusheng Qu
Yu Jiao
Jiahui Hu
Bo Wang
author_facet Shaojun Hu
Xiusheng Qu
Yu Jiao
Jiahui Hu
Bo Wang
author_sort Shaojun Hu
collection DOAJ
description Background: To classify triple-negative breast cancer (TNBC) immunotyping using the public database, analyze the differences between subtypes in terms of clinical characteristics and explore the role and clinical significance of immune subtypes in TNBC immunotherapy.Methods: We downloaded TNBC data from the cBioPortal and GEO databases. The immune genes were grouped to obtain immune gene modules and annotate their biological functions. Log-rank tests and Cox regression were used to evaluate the prognosis of immune subtypes (IS). Drug sensitivity analysis was also performed for the differences among immune subtypes in immunotherapy and chemotherapy. In addition, dimension reduction analysis based on graph learning was utilized to reveal the internal structure of the immune system and visualize the distribution of patients.Results: Significant differences in prognosis were observed between subtypes (IS1, IS2, and IS3), with the best in IS3 and the worst in IS1. The sensitivity of IS3 to immunotherapy and chemotherapy was better than the other two subtypes. In addition, Immune landscape analysis found the intra-class heterogeneity of immune subtypes and further classified IS3 subtypes (IS3A and IS3B). Immune-related genes were divided into seven functional modules (The turquoise module has the worst prognosis). Five hub genes (RASSF5, CD8A, ICOS, IRF8, and CD247) were screened out as the final characteristic genes related to poor prognosis by low expression.Conclusions: The immune subtypes of TNBC were significantly different in prognosis, gene mutation, immune infiltration, drug sensitivity, and heterogeneity. We validated the independent role of immune subtypes in tumor progression and immunotherapy for TNBC. This study provides a new perspective for personalized immunotherapy and the prognosis evaluation of TNBC patients in the future.
first_indexed 2024-12-21T10:35:16Z
format Article
id doaj.art-b2ddc5b1b8764c1fb275fe9bb8bd2618
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-21T10:35:16Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-b2ddc5b1b8764c1fb275fe9bb8bd26182022-12-21T19:07:05ZengFrontiers Media S.A.Frontiers in Genetics1664-80212021-11-011210.3389/fgene.2021.710534710534Immune Classification and Immune Landscape Analysis of Triple-Negative Breast CancerShaojun Hu0Xiusheng Qu1Yu Jiao2Jiahui Hu3Bo Wang4Oncology Department, First Affiliated Hospital of Jiamusi University, Jiamusi, ChinaChemotherapy Department, First Affiliated Hospital of Jiamusi University, Jiamusi, ChinaOncology Department, First Affiliated Hospital of Jiamusi University, Jiamusi, ChinaChemotherapy Department, First Affiliated Hospital of Jiamusi University, Jiamusi, ChinaOncology Department, First Affiliated Hospital of Jiamusi University, Jiamusi, ChinaBackground: To classify triple-negative breast cancer (TNBC) immunotyping using the public database, analyze the differences between subtypes in terms of clinical characteristics and explore the role and clinical significance of immune subtypes in TNBC immunotherapy.Methods: We downloaded TNBC data from the cBioPortal and GEO databases. The immune genes were grouped to obtain immune gene modules and annotate their biological functions. Log-rank tests and Cox regression were used to evaluate the prognosis of immune subtypes (IS). Drug sensitivity analysis was also performed for the differences among immune subtypes in immunotherapy and chemotherapy. In addition, dimension reduction analysis based on graph learning was utilized to reveal the internal structure of the immune system and visualize the distribution of patients.Results: Significant differences in prognosis were observed between subtypes (IS1, IS2, and IS3), with the best in IS3 and the worst in IS1. The sensitivity of IS3 to immunotherapy and chemotherapy was better than the other two subtypes. In addition, Immune landscape analysis found the intra-class heterogeneity of immune subtypes and further classified IS3 subtypes (IS3A and IS3B). Immune-related genes were divided into seven functional modules (The turquoise module has the worst prognosis). Five hub genes (RASSF5, CD8A, ICOS, IRF8, and CD247) were screened out as the final characteristic genes related to poor prognosis by low expression.Conclusions: The immune subtypes of TNBC were significantly different in prognosis, gene mutation, immune infiltration, drug sensitivity, and heterogeneity. We validated the independent role of immune subtypes in tumor progression and immunotherapy for TNBC. This study provides a new perspective for personalized immunotherapy and the prognosis evaluation of TNBC patients in the future.https://www.frontiersin.org/articles/10.3389/fgene.2021.710534/fulltriple-negative breast cancerTCGA databaseimmune microenvironmentimmune subtypeimmunotherapy
spellingShingle Shaojun Hu
Xiusheng Qu
Yu Jiao
Jiahui Hu
Bo Wang
Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
Frontiers in Genetics
triple-negative breast cancer
TCGA database
immune microenvironment
immune subtype
immunotherapy
title Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
title_full Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
title_fullStr Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
title_full_unstemmed Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
title_short Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
title_sort immune classification and immune landscape analysis of triple negative breast cancer
topic triple-negative breast cancer
TCGA database
immune microenvironment
immune subtype
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fgene.2021.710534/full
work_keys_str_mv AT shaojunhu immuneclassificationandimmunelandscapeanalysisoftriplenegativebreastcancer
AT xiushengqu immuneclassificationandimmunelandscapeanalysisoftriplenegativebreastcancer
AT yujiao immuneclassificationandimmunelandscapeanalysisoftriplenegativebreastcancer
AT jiahuihu immuneclassificationandimmunelandscapeanalysisoftriplenegativebreastcancer
AT bowang immuneclassificationandimmunelandscapeanalysisoftriplenegativebreastcancer